Insider Holders & Insider Ownership - Protalix BioTherapeutics Inc. (PLX)

List of insiders holdings for Protalix BioTherapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 Sheratzki Eyal
Director
10% Owner		 2007-01-05 20:27:25 0
14,466,319		 14,466,319 Form 4
2 Bio-Cell Ltd
10% Owner		 2014-09-18 17:59:19 0
10,066,319		 10,066,319 Form 4
3 Hurvitz Eli
Director		 2009-11-13 16:30:40 4,898,683
4,898,683		 9,797,366 Form 4
4 Toussia-Cohen Sharon
Director
10% Owner		 2007-01-05 20:28:07 0
6,556,381		 6,556,381 Form 4
5 Techno-Rov Holdings (1993) Ltd
10% Owner		 2007-01-05 20:28:26 0
6,186,046		 6,186,046 Form 4
6 Marathon Investments Ltd.
10% Owner		 2009-09-24 11:00:46 4,777,304
0		 4,777,304 Form 13G
7 Akirov Alfred
Director		 2020-03-30 14:12:47 3,332,862
0		 3,332,862 Form 13G
8 FROST PHILLIP MD
Frost Gamma Investments Trust
10% Owner		 2011-01-20 16:18:28 3,076,106
0		 3,076,106 Form 13D
9 Bashan Dror
PRESIDENT AND CEO		 2024-04-03 17:30:27 132,516
2,149,418		 2,281,934 Form 4
10 Dexcel Pharma Technologies Ltd.
Oren Dan
10% Owner		 2021-06-15 09:19:55 2,034,117
0		 2,034,117 Form 13G
11 Camber Capital Management LLC
10% Owner		 2017-02-14 12:01:14 1,562,933
0		 1,562,933 Form 13G
12 Manor Moshe
President & CEO		 2018-09-14 16:30:40 1,300,000
0		 1,300,000 Form 4
13 HSIAO JANE PH D
Director		 2007-02-02 18:18:06 1,134,060
0		 1,134,060 Form 4
14 Maimon Yossi
VP, Chief Financial Officer		 2018-09-14 16:31:39 700,000
0		 700,000 Form 4
15 Shaaltiel Yoseph
Executive VP, R&D		 2018-09-14 16:30:18 700,000
0		 700,000 Form 4
16 Rubin Eyal
Sr. VP and CFO		 2024-11-05 17:00:15 0
660,909		 660,909 Form 4/A
17 Aviezer David
President & CEO		 2012-07-18 16:31:13 0
418,000		 418,000 Form 4
18 Katz Iftah
VP of Operations		 2007-06-13 15:50:55 204,351
0		 204,351 Form 4
19 Almon Einat Brill
SVP, Chief Development Officer		 2020-06-08 17:07:44 196,995
0		 196,995 Form 4
20 Yanai Shlomo
Director		 2014-07-24 16:35:33 150,000
0		 150,000 Form 4
21 Palash Tzvi
Chief Operating Officer		 2015-05-07 17:23:01 125,000
0		 125,000 Form 4
22 Naos Yaron
Sr. VP, Operations		 2024-09-24 17:00:07 100,000
0		 100,000 Form 4
23 Bronfeld Zeev
Director		 2022-09-09 17:01:49 100,000
0		 100,000 Form 4
24 Forster Eliot
Director		 2023-09-15 16:46:57 85,715
0		 85,715 Form 4
25 Hayon Yael
VP, Research & Development		 2023-08-17 16:30:28 35,115
35,115		 70,230 Form 4
26 Schwartz Aharon
Director		 2023-10-03 17:00:32 61,676
0		 61,676 Form 4
27 Ben Zvi Shmuel
Director		 2023-10-03 17:00:50 61,676
0		 61,676 Form 4
28 Bar-Shalev Amos
Director		 2023-10-03 17:00:51 61,676
0		 61,676 Form 4
29 Melincoff Gwen A
Director		 2023-10-03 17:00:54 61,676
0		 61,676 Form 4
30 Boudes Pol F
Director		 2023-10-03 17:00:58 61,676
0		 61,676 Form 4
31 Kornberg Roger D.
Director		 2008-09-08 20:26:12 50,000
0		 50,000 Form 4
32 Granot David
Director		 2020-01-22 17:03:26 40,000
0		 40,000 Form 4
33 Lauterbach Sandra Leigh
VP, Sales & Commercial Affairs		 2012-07-18 16:40:33 0
20,000		 20,000 Form 4
34 Lockshin Curtis
Director		 2007-03-29 17:00:07 0
0		 0 Form 3
35 Buchris Pinhas Barel
Director		 2007-01-05 19:33:15 0
0		 0 Form 3
36 Gross Yodfat Harel
Director		 2007-07-12 17:12:04 0
0		 0 Form 3